Navigation Links
New Hope for Parkinson's Patients
Date:6/24/2008

Experimental drug, patch for current drug both control symptoms better, studies show

TUESDAY, June 24 (HealthDay News) -- A new medication and an improved delivery system for an older drug appear to hold promise for taming the symptoms of Parkinson's disease.

In the first study, patients taking the drug SLV308 showed significant reductions in typical Parkinson's symptoms, such as tremors and slowness of movement. The results also indicate that SLV308 alone may help patients in the early stages of Parkinson's disease.

Patients appeared to tolerate SLV308 well, although it did cause side effects such as nausea, dizziness, drowsiness, headache and weakness. The study was supported by the drug's maker, Solvay Pharmaceuticals.

In the second study, a patch delivery system for levodopa also appeared to ease motor problems in Parkinson's patients.

The study compared healthy volunteers on a levodopa patch against those taking carbidopa orally every eight hours over a 24-hour period. Those with the patch appeared to receive a more constant therapeutic delivery of medication.

"If levodopa can be administered in a way to bypass the gastrointestinal tract, which is responsible for the vagaries which complicate levodopa dosing in [Parkinson's] patients now, it would be an important step forward," Dr. John Nutt, of Oregon Health & Science University, said in a prepared statement. "Transdermal administration would produce more constant plasma levels than can be achieved with oral dosing, which should reduce motor fluctuations and possibly, dyskinesia."

The results of the studies were presented this week at the Movement Disorder Society's 12th International Congress of Parkinson's Disease and Movement, in Chicago.

More information

We Move has more about Parkinson's disease.



-- Kevin McKeever



SOURCE: Movement Disorder Society, news release, June 24, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Hope for Parkinson's Patients
(Date:5/27/2016)... SC (PRWEB) , ... May 27, 2016 , ... ... a line of classic American timber frame barn kits, which can be found on ... are inspired by historic American barn plans, and they highlight the craftsmanship of timber ...
(Date:5/27/2016)... ... ... An influential resource amongst nurses and professionals in the health care world, ... of topics detailing why we appreciate nurses in so many different ways. From exclusive ... being in a major recession to one of the hottest growing professions in any ...
(Date:5/27/2016)... ... May 27, 2016 , ... An ... bolstered by inspiring human-interest stories, courtesy of awareness-driven celebrities and thought leaders. It ... leading advocates, associations and industry leaders such as Bioness. , As patients ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... installment is bolstered by inspiring human interest stories, courtesy of leaders in the ... and tech within the industry, from leading advocates and associations—namely Jones & Bartlett ...
(Date:5/27/2016)... ... May 27, 2016 , ... ... the pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center ... proof of successfully certified products, services and staff. , Validation Center is ISO17025 ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
(Date:5/24/2016)... 2016 Niederländische Chirurgen haben ... es Ärzten erlaubt, ihre Expertise weltweit zu teilen ... Live Streaming mit einer Instant-Messaging-Funktion und der Möglichkeit, ... in Europa, Afrika, Asien und den ... Plattform registriert. Information und Weiterbildung   ...
(Date:5/24/2016)...   , Study met both ... superiority in , Excellent plus Good ... of the ascending colon   , ... today announced new positive data from the phase III MORA study ... 2 litre PEG with ascorbate. The study met both primary endpoints ...
Breaking Medicine Technology: